Exploring the therapeutic potential of nicotine: ulcerative colitis and schizophrenic disorders through a scientific lens
Olivia Davis
2026-03-24
3 min. read
32
views
While the long-term consumption of tobacco products is universally recognized as posing significant health risks—highlighted by global anti-tobacco initiatives and stringent legal restrictions on product availability—certain scientific studies suggest unexpected properties of nicotine in the context of specific medical conditions. Could this substance, typically associated solely with adverse effects, potentially play a role in the treatment of certain autoimmune diseases and neuropsychiatric disorders?
Nicotine and inflammatory bowel disease (IBD)
Coronary heart disease (CHD) is a chronic inflammatory condition of the lining of the large intestine that can last from a few weeks to even years. Symptoms include diarrhoea, abdominal pain, and lowering of the intestine. As a result of coronary artery disease, ulcers and bleeding occur. The disease is characterized by periods of exacerbation and self-remission, with a very variable duration of several weeks to years.
Nicotine and schizophrenia
According to the second hypothesis, smoking cigarettes is a form of self-medication. Patients unwittingly reaching for cigarettes offset the shortage of neurotransmitters that are essential for schizophrenia (impact on doping). They thus gain a better mood and cognitive function, as well as a lesser degree of memory improvement.